期刊文献+

再生障碍性贫血患者血清对人骨髓间充质干细胞凋亡的影响 被引量:3

The effects of serum from patients with aplastic anemia on the apoptosis of human bone marrow mesenchymal stemcells
原文传递
导出
摘要 再生障碍性贫血(AA)是一组由化学、物理、生物等不明原因引起骨髓造血干细胞及造血微环境损伤、造血功能进行性衰竭及全血细胞减少的疾病[1]。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第2期168-169,共2页 Chinese Journal of Hematology
基金 南通市科技计划社会发展项目(S7945)
  • 相关文献

参考文献8

二级参考文献70

  • 1Hasegawa H, Yamada Y, Komiyama K, et al. A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production. Blood 2007; 110(5): 1664-1674
  • 2Fas SC, Baumann S, Zhu JY, et al. Wogonin sensitizes resistant malignant ceils to TNFalpha- and TRAIL-induced apoptosis. Blood 2006;108(12):3700-3706
  • 3Wissink EH,Verbrugge l, Vink SR,et al. TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy. Radiother Oncol 2006; 80(2): 214-222
  • 4Garofalo M, Romano G, Quintavalle C, et al. Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis, Int-J-Cancer 2007; 120(6): 1215-1222
  • 5Ivanov VN, Hei TK. Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression. Exp Cell Res 2006; 312(20): 4120-4138
  • 6Secchiero P, Zerbinati C, di-Iasio MG, et al. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells. Curr Drug Metab 2007; 8(4): 395-403
  • 7Baetu TM, Hiscott J. On the TRAIL to apoptosis. Cytokine Growth Factor Rev 2002; 13 (3): 199-207
  • 8Szegezdi E, CahiU S, Meyer M, et al. TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt. Br J Cancer 2006; 94(3): 398-406
  • 9MacFarlane M, Kohlhaas SL, Sutcfiffe MJ, et al. TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies. Cancer Res 2005; 65(24): 11265-11270
  • 10Liu LG, Tanaka H, Ito K, et al. Absence of gene mutation in TRAIL receptor 1 (TRAIL-RI) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia. Acta Haematol 2005; 113(2): 113-123

共引文献5

同被引文献17

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部